Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Oncology
|
October 11, 2014
Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patients
Abby B Siegel, Abhishek Goyal, Marcela Salomao, et al.
Journal for Immunotherapy of Cancer
|
November 18, 2021
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study
Fangwen Zou, David Faleck, Anusha Thomas, et al.
Igie : Innovation, Investigation and Insights
|
July 3, 2026
Validation of the immune-mediated colitis endoscopic score using a retrospective cohort of patients with immune-mediated colitis
Malek Shatila, Carolina Colli Cruz, Krishnavathana Varatharajalu, et al.
Endoscopy International Open
|
April 18, 2022
Endoscopic submucosal dissection for colorectal dysplasia in inflammatory bowel disease: a US multicenter study
Saowanee Ngamruengphong, Hiroyuki Aihara, Shai Friedland, et al.
Inflammatory Bowel Diseases
|
May 23, 2018
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease
Eugenia Shmidt, Gursimran Kochhar, Justin Hartke, et al.
Gastrointestinal Endoscopy
|
January 25, 2024
Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients
Yinghong Wang, Hamzah Abu-Sbeih, Tenglong Tang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 1, 2018
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases
Joseph Meserve, Satimai Aniwan, Jenna L Koliani-Pace, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 11, 2020
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
Dana Lukin, David Faleck, Ronghui Xu, et al.
The American Journal of Gastroenterology
|
November 4, 2018
Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Neeraj Narula, Farhad Peerani, Joseph Meserve, et al.
The American Journal of Gastroenterology
|
June 28, 2018
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Neeraj Narula, Farhad Peerani, Joseph Meserve, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Oncology
|
October 11, 2014
Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patients
Abby B Siegel, Abhishek Goyal, Marcela Salomao, et al.
Journal for Immunotherapy of Cancer
|
November 18, 2021
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study
Fangwen Zou, David Faleck, Anusha Thomas, et al.
Igie : Innovation, Investigation and Insights
|
July 3, 2026
Validation of the immune-mediated colitis endoscopic score using a retrospective cohort of patients with immune-mediated colitis
Malek Shatila, Carolina Colli Cruz, Krishnavathana Varatharajalu, et al.
Endoscopy International Open
|
April 18, 2022
Endoscopic submucosal dissection for colorectal dysplasia in inflammatory bowel disease: a US multicenter study
Saowanee Ngamruengphong, Hiroyuki Aihara, Shai Friedland, et al.
Inflammatory Bowel Diseases
|
May 23, 2018
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease
Eugenia Shmidt, Gursimran Kochhar, Justin Hartke, et al.
Gastrointestinal Endoscopy
|
January 25, 2024
Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients
Yinghong Wang, Hamzah Abu-Sbeih, Tenglong Tang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 1, 2018
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases
Joseph Meserve, Satimai Aniwan, Jenna L Koliani-Pace, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 11, 2020
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
Dana Lukin, David Faleck, Ronghui Xu, et al.
The American Journal of Gastroenterology
|
November 4, 2018
Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Neeraj Narula, Farhad Peerani, Joseph Meserve, et al.
The American Journal of Gastroenterology
|
June 28, 2018
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Neeraj Narula, Farhad Peerani, Joseph Meserve, et al.
Page
of 3